FEB 19, 2020 2:29 AM PST

Rainbow trout hold the key to unravelling immunological mysteries

WRITTEN BY: Tara Fernandez

What do the gut microbiome, antibodies, and rainbow trout have in common? A lot, says researcher J. Oriol Sunyer from the University of Pennsylvania’s School of Veterinary Medicine.

As the featured cover story of a recent edition of Science Immunology, Sunyer and colleagues have led a study to better understand the biology of mucosal antibodies, using a unique experimental model — the rainbow trout. In particular, the scientists were interested in IgT, a highly specialized and primitive immunoglobulin, which is specifically associated with mucous membranes.

Examining the microbiome dynamics in the mucosal lining of trout gills revealed that the role that IgT plays in immune protection is indeed a complex one. This antibody performs two seemingly contradictory functions, one to resist the overgrowth of pathogenic bacteria, while simultaneously creating an environment where healthy, beneficial bacteria flourish. 

Rodents and cell culture systems have been far more commonly-used experimental models of immunology. So, why trout? "Fish are the earliest bony vertebrates to possess a mucosal immune system, and so the fact that fish possess a specialized immunoglobulin that does both jobs suggests that these two processes are so fundamentally important for vertebrate survival that they arose concurrently, early on in evolution," says Sunyer, who has been using fish models to answer evolutionary and immunological questions for over two decades.

In mammals, the immunoglobulin IgA seems to be the most analogous to IgT in fish. IgA coats vast surface areas of the respiratory, gastrointestinal and genitourinary tracts and are important mediators of preventing pathogenic microorganisms from invading. Disruptions to IgA-mediated protection could see a shift in the microbiome landscape within these tissues. As more and more emerging evidence is suggesting, such changes to the microbiome are critical drivers in the development of metabolic, malignant and even neurological conditions.

Sunyer believes that we cannot solely rely on mammalian systems to address these difficult immunological questions, saying, “Rainbow trout will help us discover the underlying mechanisms by which the interactions between immunoglobulins and the microbiome influence immunity, metabolism, cancer, and much more."

 

 

Sources: Science Daily, Science Immunology

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 03, 2020
Immunology
A Low-Cost COVID-19 Treatment, Made in Horses
SEP 03, 2020
A Low-Cost COVID-19 Treatment, Made in Horses
Researchers in Costa Rica are turning to horses as an unlikely source of potential therapeutic antibodies against COVID- ...
SEP 17, 2020
Immunology
COVID Vaccine Works in Macaques - What about in Humans?
SEP 17, 2020
COVID Vaccine Works in Macaques - What about in Humans?
Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown ...
OCT 20, 2020
Immunology
The Immune Pause Button Slowing MS Progression
OCT 20, 2020
The Immune Pause Button Slowing MS Progression
  Scientists have a new theory about the genetics behind the progressive, debilitating effects of multiple sclerosi ...
NOV 16, 2020
Immunology
Australian COVID-19 vaccine is promising and could be released next year
NOV 16, 2020
Australian COVID-19 vaccine is promising and could be released next year
Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and he ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
Loading Comments...